BMI1 and cancer: In addition to CSC markers, targeting cancer stemness genes has been found to have potential for EC treatment, such as B-lymphoma Mo-MLV insertion region 1 (BMI1) [26] or homeobox transcription factor Nanog (NANOG) [27].